Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 85509-1076

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 85509-1076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Ondansetron 8 mg Label Text 1)

Label (Ondansetron 8 mg Label Text 1)
Ondansetron Tablets USP 8 mg film-coated tablets package label showing 30 tablets. Manufactured by Aurobindo Pharma Limited and repackaged by PHOENIX RX LLC, Hatboro, PA. Includes storage instructions and a QR code to the package insert. NDC number 85509-1076-3 is displayed.*
FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical Structure (Ondansetron Str)
Chemical structure of Ondansetron Hydrochloride depicting its molecular framework, including an indole moiety, a methylated nitrogen, and a substituted imidazole ring with associated hydrochloride and dihydrate components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.